RushNet, Inc. (OTCPK:RSHN) announced the spin-off of Chattahoochee Physicians Laboratory Services, LLC on June 17, 2021. RushNet Inc. shareholders will receive 1 share outright in heliosDX per 1000 shares owned in RushNet. They will also receive, for each share held, rights to purchase at a discount, up to 11 shares in heliosDX per 1000 shares owned in RushNet. Shareholders will also receive a dividend in the RushNet spinoff to be determined soon. RushNet will spinoff heliosDX and soon thereafter RushNet itself, with its current assets, will spinoff. Each spinoff entity will become a publicly traded entity. heliosDX will be domiciled in Georgia. The mechanics will involve heliosDX filing a Form 1-A, Tier 2, to qualify all shares issued in pursuit of this spinoff, thus affording RushNet shareholders the opportunity to acquire additional shares at a discount to the market price. The proceeds from the offering will be utilized to close previously announced targeted acquisition candidates. Avuthorized Shares estimated to be 40,000,000. Approximately 5% of these shares will be restricted and owned by Ashley Sweat, Chairman and Chief Executive Officer of heliosDX. In addition, Sweat will receive Convertible Preferred Stock. After completing both spinoffs, Ashley Sweat will remain as the Chairman and Chief Executive Officer of RushNet, Inc.